Nuvalent (NUVL) Amortizatization of Intangibles (2021 - 2026)

Nuvalent (NUVL) posted Amortizatization of Intangibles of $1.8 million for Q1 2026, down 90.98% on a QoQ basis from $20.3 million in Q4 2025, and down 57.27% year-over-year from $4.3 million in Q1 2025.

Nuvalent (NUVL) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends

Nuvalent's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $1.8 million for Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 57.27% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (down 61.25% YoY) and the FY2025 annual result came in at $11.1 million, down 24.28% from the prior year.
  • Amortizatization of Intangibles was $1.8 million for Q1 2026 at Nuvalent, down from $20.3 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $24.4 million in Q4 2024 and bottomed at -$11.3 million in Q2 2025.
  • A 5-year average of $2.2 million and a median of -$833000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • Peak annual rise in Amortizatization of Intangibles reached 2275.99% in 2023, while the deepest fall reached 87566.67% in 2023.
  • Nuvalent's Amortizatization of Intangibles stood at -$833000.0 in 2022, then jumped by 2275.99% to $18.1 million in 2023, then jumped by 34.64% to $24.4 million in 2024, then slipped by 16.89% to $20.3 million in 2025, then slumped by 90.98% to $1.8 million in 2026.
  • Business Quant data shows NUVL's Amortizatization of Intangibles at $1.8 million in Q1 2026, $20.3 million in Q4 2025, and -$2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - 1.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.83 Mn
Mar 31, 2026 1.83 Mn
Dec 31, 2025 20.28 Mn
Dec 31, 2025 20.28 Mn
Sep 30, 2025 -2.19 Mn
Sep 30, 2025 -2.19 Mn
Jun 30, 2025 -11.27 Mn
Jun 30, 2025 -11.27 Mn
Mar 31, 2025 4.28 Mn
Mar 31, 2025 4.28 Mn
Dec 31, 2024 24.41 Mn
Dec 31, 2024 24.41 Mn
Sep 30, 2024 -2.92 Mn
Sep 30, 2024 -2.92 Mn
Jun 30, 2024 -3.43 Mn
Jun 30, 2024 -3.43 Mn
Mar 31, 2024 -3.38 Mn
Mar 31, 2024 -3.38 Mn
Dec 31, 2023 18.13 Mn
Dec 31, 2023 18.13 Mn